Davis Polk, HSF act on Chinese biopharma firm’s $335 mln HK IPO
BY Aparna Sai |
Davis Polk & Wardwell and Zhong Lun Law Firm advised Chinese biopharmaceutical company Antengene Corporation on its $335 million IPO in Hong Kong, with Herbert Smith Freehills and Commerce & Finance Law Offices advising the joint sponsors and the underwriters.